Bristol-Myers Squibb Company (NYSE: BMY) and Nektar Therapeutics (Nasdaq: NKTR) announced a new clinical collaboration to evaluate Bristol-Myers Squibb’s Opdivo ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE